Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy

American Journal of Kidney Diseases

Volumn 45, Issue 2, 2005, Pages 288-294

  Kanesaki, Yoshinobu ^b   Suzuki, Daisuke ^b   Uehara, Goro ^b   Toyoda, Masao ^b   Katoh, Tetsuo ^a   Sakai, Hideto ^b   Watanabe, Tsuyoshi ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Diabetic nephropathy; Extra vessels; In situ hybridization; Mesangial matrix

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTERIOLE; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; MICROSCOPY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 15944376565     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.09.020     Document Type: Article

References (19)

1. L.E. Brown, B. Berse, K. Tognazzi Vascular permeability factor mRNA and protein expression in human kidney Kidney Int 42 1992 1457 1461
2. M. Simon, H.J. Grone, O. Joren Expression of vascular endothelial growth factor and its recepters in human renal ontogenesis and in adult kidney Am J Physiol 268 1995 F240 F250
3. M.E. Cooper, D. Vranes, S. Youssef Increased renal expression of vascular endothelial growth factor (VEGF) and its recepter VEGFR-2 in experimental diabetes Diabetes 48 1999 2229 2239
4. D.R. Cha, N.H. Kim, J.W. Yoon Role of vascular endothelial growth factor in diabetic nephropathy Kidney Int Suppl 77 2000 S104 S112
5. M. Wen, N. Yamanaka Three-dimensional analysis of increased vascular around the glomerular vascular pole in diabetic nephropathy Virchow Archiv A Pathol Anat 423 1993 201 207
6. A. Onozaki, S. Midorikawa, H. Sanada Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF Inhibitory effects of thiazolidinedione Biochem Biophys Res Comnun 317 2004 24 29
7. D. Suzuki, T. Miyata, M. Nangaku Expression of Megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular disease Am J Soc Nephrol 10 1999 2606 2613
8. M. Toyoda, D. Suzuki, S.Y. Zhang, T. Umezono, H. Sakai In-situ hybridization studies of protein kinase Cα and β1 isoforms in human diabetic nephropathy Clin Exp Nephrol 5 2001 250 256
9. S.Y. Zhang, D. Suzuki, T. Umezono, M. Toyoda, H. Sakai Expression of connective tissue growth factor mRNA in human IgA nephropathy Clin Exp Nephrol 5 2001 33 39
10. M. Kuriki, K. Asahi, K. Asano Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy Nephrol Dial Transplant 18 2003 1311 1315
11. R. Østerby, J. Asplund, H.J. Bangstand Neovascularization at the vascular pole region in diabetic glomerulopathy Nephrol Dial Transplant 14 1999 348 352
12. M. Kanauchi, K. Ishihara, H. Nishioka, K. Nishiura Glomerular lesions in patients with non-insulin-dependent diabetes mellitus and microalbuminuria Intern Med 32 1993 753 757
13. R. Østerby, H. Jorgen, G. Nyberg Advanced diabetic glomerulopathy Quantitative structural characterization of nonoccluded glomeruli Diabetes 36 1987 612 619
14. N.H. Kim, H.H. Jung, D.R. Cha, D.S. Choi Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells J Endocrinol 165 2000 617 624
15. A.S. De Vriese, R.G. Tilton, M. Elger, C.C. Stephan, W. Kriz, N.H. Lameire Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes J Am Soc Nephrol 12 2001 993 1000
16. K. Tsuchida, Z. Makita, S. Yamaguchi Supression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 Diabetologia 42 1999 579 588
17. R. Østerby, J. Tapia, G. Nyberg Renal structures in type 2 diabetic patients with elevated albumin excretion rate APMIS 109 2001 751 761
18. C. Tai-Gen, R.F. Rebecca, S. Moin Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein Am J Physiol Renal Physiol 286 2004 F767 F773
19. O.B. David, C. Tai-gen, M.D. Joanne VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma Cancer Res 62 2002 4123 4131